One in every five individuals worldwide experiences symptoms of mental health illness, according to the World Health ...
Provinces will make final call over coverage of Pluvicto treatment, which costs $27K per dose An organization representing Canada's public drug plans has come to a deal with a pharmaceutical ...
The US Food and Drug Administration had just approved VNS in 2005 for the long-term adjunctive treatment of chronic or recurrent depression ... Conway plans to continue discussions with the ...
Genomic profiling in the FLEX trial predicted chemotherapy response in HR+, HER2- breast cancer, which could enable tailored treatment plans. Dr. Brufsky: The FLEX study is a large-scale, prospective, ...
territorial and federal health plans, and Novartis broke off negotiations, leaving patients without coverage for Pluvicto — the brand name for a treatment that kills cancer cells with the ...
Speaker Mike Johnson (R-La.) is looking at a plan B to fund the government ahead of Friday’s shutdown deadline as Republicans inside and outside the Capitol, including President-elect Trump and ...
One of the most notable scientific papers that first popularized hydroxychloroquine as a COVID-19 treatment was retracted ... about the paper given the small sample size and short peer-review ...
In 2019, the Food and Drug Administration (FDA) approved the first treatment specifically for postpartum depression — a drug called brexanolone (Zulresso). Doctors will inject this medication di ...
However, the Chiefs quarterback has revealed he still plans to play, even through his significant ankle injury. #Chiefs QB Patrick Mahomes says his ankle has done good with the treatment ...
The steps you take each day could lead you to a reduction in depression symptoms ... so make a backup plan as if your happiness depended on it,” Noetel said. “Because it does.” ...
whose collapse had kicked off the Great Depression. Apparently, the president-elect’s transition team sees this period as America’s glory days. Some of Trump’s 1930s-ish plans have received ...